 REDWOOD CITY, Calif.--BUSINESS WIRE--Pulmonx Corporation Nasdaq: LUNG Pulmonx a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in fireside chats at two upcoming investor conferences. Pulmonx management is scheduled to participate in the 2022 Wells Fargo Healthcare Conference in Boston on Wednesday, September 7, 2022, at 6:10am PT 9:10am ET and the Morgan Stanley 20th Annual Global Healthcare Conference in New Y 